30. Ogas Castells, M.L., La Torre, J.L., Grigera, P.R., Poggio, T.V. A single dose of a suicidal DNA
vaccine induces a specific immune response in salmonids. Journal of Fish Diseases (2015) Jun; 38(6):581-7. doi: 10.1111/jfd.12274. Epub 2014 Aug 8.

31. Palacios, C., Torioni de Echaide, S. and N. Mattion. Evaluation of the immune response to
Anaplasma marginale MSP5 protein using a HSV-1 amplicon vector system or recombinant protein. Res.
Vet. Sci. 2014, 97, 514-520.

32. León E., Perez A., Stevenson M.A., Robiolo B., Mattion N., Seki C., La Torre J., Torres A.,
Cosentino B., Duffy S.J. Effectiveness of foot and mouth disease systematic mass vaccination campaigns
in Argentina. Rev. Sci. Tech. 2014, Volume 33 (3), 917-926.

33. Giacomodonato MN, Noto Llana M, Aya Castañeda MR, Buzzola FR, Gallo Calderón M, Sarnacki
SH, Rubino S, Cerquetti MC. Dam methylation regulates the expression of SPI-5-encoded sopB gene in
Salmonella enterica serovar Typhimurium. Microbes and Infection 16 (2014) 615-622.

34. Kenton, M.; Handel, I; Tanya, V; Hamman, S; Nfon, C; Bergmann, I; Malirat, V; Sorensen, K;
Bronsvoort, M. Accuracy of herdsmen reporting versus serologic testing for estimating Foot-and-Mouth
Disease prevalence. Emerging Infectious Diseases. 2014. Vol 20 n°12. p2048 -2054.

35. Maradei E, Malirat V, Perez Beascoechea C, Espinoza A, Galdo Novo S, Smitsaart E, Salgado G,
Mattion N, Rodriguez Toledo J, Bergmann I. Emergence of antigenic variants of Foot-and-Mouth Disease
Virus serotype O in Ecuador and preliminary evaluation of a field strain as a vaccine candidate. Vaccine
2014, 32, 2446-2451.

36. Alejandra D’Antuono, Maria Eugenia Loureiro, Sabrina Foscaldi, Cristina Marino Buslje, and Nora
López. Differential contribution of Tacaribe arenavirus Nucleoprotein N-terminal and C-terminal
residues to nucleocapsid functional activity. Journal of Virology 2014, Jun; 88(11):6492-505,

37. Campos, R., Veiga, C., S., B, Meneses, M., D., F., Fernandes, C., A., S., Malirat, V., Albuquerque, J., P.,
Tanuri, A., Schmidt-Chanasit, J., Ferreira, D., F. Emergence of Dengue virus 4 genotypes II b and I in the city
of Rio de Janeiro. Journal of Clinical Virology. 2013 Jan;56(1):86-8.

38. Sarute, N.; Gallo Calderón, M.; Pérez, R., La Torre, J.; Hernández, M.; Francia, L.; Panzera, Y. The
fusion protein signal-peptide of canine distemper virus: a useful genomic region to identify genetic
lineages. Plos One (May 2013) Volume 8, Issue 5,e63595.

39. Maradei E, Malirat V, Perez Beascoechea C, Oviedo Benitez E, Pedemonte A, Seki C, Galdo Novo
S, Balette C, D’Aloia R, La Torre J, Mattion N, Rodriguez Toledo J, Bergmann I. Characterization of a type
O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of
South America and cross-protection studies with the vaccine strain in use in the region. VeterinaryMicrobiology 2013, 162, 479–490.

40. Romanutti C, D’Antuono A, Palacios C, Quattrocchi V, Zamorano P, La Torre J and N Mattion.
Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid
proteins and boosted with inactivated virus. Vet. Mic. 2013, 165, 333-340.

41. Alvarez P., Zylberman V, Ghersi G, Boado L, Goldbaum F and N. Mattion. (2012). Tandem repeats
of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase
decameric carrier molecule induce protection in mice. Vaccine 2013, 31 (5), 806-812.

42. Cargnelutti DE, Sanchez MA, Alvarez P, Boado L, Mattion N, Scodeller EA. Enhancement of Th1
immune responses to recombinant influenza nucleoprotein by Ribi adjuvant. New Microbiol 2013,

43. Claudia S. Sepúlveda, Cybele C. García, Jesica M. Levingston Macleod, Nora López†, Elsa B.
Damonte†. Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with
virucidal activity. PLoS ONE, November 2013, Volume 8, Issue 11, e81251. †both authors contributed
equally to this work and share the senior author position.

44. Cargnelutti D., Sanchez M., Mattion N., Scodeller E. Development of a universal CTL-based
vaccine for influenza. Bioengineered 2013, 4(6), 1-5.

45. Laimbacher A., Esteban L., Castello A., Abdusetir Cerfoglio J., Argüelles M, Glikmann G., D’Antuono
A., Mattion N., Berois M., Arbiza J., Hilbe M., Schraner E., Seyffert M., Dresch C., Epstein A., Ackermann M.,
and C. Fraefel. HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles
and induce rotavirus-specific immune responses in mice. Molecular Therapy 2012, 20, 1810-1820.

46. Malirat V., Bergmann I.E, Campos R.de M., Conde F., Quiroga JL., Villamil, M., Salgado G., Ortiz S.,
Molecular epidemiology of foot-and-mouth disease virus type A in South America. Veterinary Microbiology,
2012. 158: 82-94.

47. Cargnelutti, D.E., Sanchez M., Alvarez P., Boado L., Glikmann G., Mattion N., and Scodeller E. A.
Improved Immune Response to Recombinant Influenza Nucleoprotein Formulated with ISCOMATRIX. J.
Microbiol. Biotechnol. 2012, 22(3), 416–421.

48. Calderón M., Wilda M., Boado L., Keller L., Malirat V., Iglesias M., Mattion N., La Torre J. Study of
Canine Parvovirus evolution: Comparative analysis of full length VP2 gene sequences from Argentina
and international field strains. Virus Genes 2012, 44:32-39.

49. Loureiro, M.E.; D’Antuono, A.; Levingston Macleod, J.M.; López, N. Uncovering Viral Protein-
Protein Interactions and their Role in Arenavirus Life Cycle. Viruses 4: 1651-1667 (2012).

50. Calderón M., Romanutti C., D’ Antuono A., Keller L., Mattion N. and La Torre J. Evolution of
Canine Parvovirus in Argentina between years 2003 and 2010: CPV2c has become the predominant
variant affecting the domestic dog population. Virus Research 2011, 157: 106-110.

51. Malirat V., Bergmann I.E, Campos R.de M., Salgado G. Sanchez C., Conde F., Quiroga JL.,Ortiz S.,
Phylogenetic analysis of Foot-and-Mouth Disease Virus type O circulating in the Andean region of South
America during 2002–2008. Veterinary Microbiology, 2011. 152 74–87.

52. Aguirre S., Malirat V., Scodeller E. and N. Mattion. First full-length genomic sequence of a
hepatitis A virus isolated in Argentina shows recombination between subgenotypes IA and IB. VirusResearch 2011, 155:316–324.

53. María Eugenia Loureiro, Maximiliano Wilda, Jesica M. Levingston Macleod, Alejandra
D’Antuono, Sabrina Foscaldi, Cristina Marino Buslje, and Nora Lopez. Molecular determinants of
Arenavirus Z protein homo-oligomerization and L polymerase binding. Journal of Virology 85:
12304–12314 (2011).

54. Jesica M. Levingston Macleod, Alejandra D’Antuono, Maria Eugenia Loureiro, Juan Cruz
Casabona, Guillermo A. Gomez and Nora López. Identification of Two Functional Domains within the
Arenavirus Nucleoprotein. Journal of Virology 85: 2012–2023 (2011).

55. D’Antuono A, Laimbacher A.S, Tribulatti V,. Romanutti C., Zamorano P., Quattrocchi V., Schraner
E, La Torre J., Ackerman M, Fraefel C, and N. Mattion. . HSV-1 amplicon vectors that direct the in situ
production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic
immunization. Vaccine 2010, 28:7363–7372.

56. Panzera, Y.; Gallo Calderón, M.; Sarute, N.; Guasco, S.; Cardeillac, A.; Bonilla, B.; Hernandez, M.;
Francia, L., Bedó, G.; La Torre, J.; Perez, R. Evidence of two co-circulating genetic lineages of canine
distemper virus in South America. Virus Research. 163. (2012) 401-404. Elsevier Science.

57. Wilda M, Lavoria MÁ, Giráldez A, Franco-Mahecha OL, Mansilla F, Érguiz M, Iglesias ME, Capozzo
AV. Development and preliminary validation of an antibody filtration-assisted single-dilution
chemiluminometric immunoassay for potency testing of Piscirickettsia salmonis vaccines. Biologicals.
2012 Nov; 40(6):415-20. doi: 10.1016/j.biologicals.2012.09.003.

58. Mansilla FC, Franco-Mahecha OL, Lavoria MÁ, Moore DP, Giraldez AN, Iglesias ME, Wilda M,
Capozzo AV. The immune enhancement of a novel soy lecithin/β-glucans based adjuvant on native
Neospora caninum tachyzoite extract vaccine in mice. Vaccine. 2012 Feb 1; 30(6):1124-31. 2012.

59. Maradei E., Perez Beascoechea C., Malirat V., Salgado G., Seki C., Pedemonte A., Bonastre P.,
D’Aloia R., La Torre J., Mattion N., Rodríguez Toledo J., Bergmann I. Characterization of foot-and-mouth
disease virus from outbreaks in Ecuador during 2009–2010 and cross-protection studies with the vaccine
strain in use in the region. Vaccine 2011, 29:8230-8240.

60. Capozzo AV, Wilda M, Bucafusco D, de los Ángeles Lavoria M, Franco-Mahecha OL, Mansilla FC,
Pérez-Filgueira DM, Grigera PR. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of
Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
Antiviral Res. 2011 Nov; 92(2):219-27. 2011.

61. Franco Mahecha, Olga Lucía; Ogas Castells, María Lorena, Combessies, Gustavo; Lavoria, María
de los Ángeles, Wilda, Maximiliano; Mansilla, Florencia; Seki, Cristina; Grigera, Pablo Rafael and
Capozzo, Alejandra Victoria. Single dilution Avidity-Blocking ELISA as an alternative to the Bovine Viral
Diarrhea Virus neutralization test. Journal of Virological Methods, 175 (2): 228-235. 2011.

62. Robiolo B, La Torre J, Maradei E, Perez Beascoechea C, Perez A., Seki C, Smitsaart E, Fondevila N,
Palma E, Goris N., De Clercq K and Mattion N. Confidence in indirect assessment of foot-and-mouth
disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization
tests. Vaccine 2010, 28: 6235-6241.

63. Robiolo B., La Torre J., Duffy S., Leon E., Seki C., Torres A. and N. Mattion. Quantitative single
serum dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and
expectancy of protection against foot-and-mouth disease virus in vaccinated cattle. J Virol Methods
2010, 166:21-27.